Great Britain Moves Toward First CBD Novel Food Authorizations
Great Britain CBD labeling compliance audit
Great Britain is moving closer to its first formal CBD novel food authorizations, potentially bringing thousands of existing products into a clearer regulatory framework. The Food Standards Agency has recommended authorization of three high purity CBD applications linked to approximately 3,000 products already listed within the existing market. The recommendations cover CBD ingredients from Chanelle McCoy CBD Ltd., Cannaray Brands Ltd., and EIHA projects GmbH. Final authorization has not occurred yet, but the development marks an important shift from temporary market access toward formal food compliance.
Quick facts
• The Food Standards Agency recommended authorization of three CBD novel food applications
• The applications are linked to approximately 3,000 CBD products already on the market
• The three applicants are Chanelle McCoy CBD Ltd., Cannaray Brands Ltd., and EIHA projects GmbH
• The applications involve CBD ingredients with purity of at least 98 percent
• The Food Standards Agency considers a provisional acceptable daily intake of 10 milligrams of CBD for a healthy adult
• Proposed conditions limit use to adults and require warnings for specified groups
• Warning groups include people under 18, pregnant or breastfeeding consumers, people trying to conceive, people taking medication, and people who are immunosuppressed
• Product specifications would place limits on delta 9 THC and other controlled cannabinoids
• The Cannaray application also covers use of its CBD isolate in certain beverages and confectionery products
• The Food Standards Agency board is scheduled to consider the recommendations on September 16
• Final authorization still requires government approval
• Products appearing on the existing CBD Public List are not currently formally authorized simply because they appear on that list
• The universal operator lesson is simple: formal market access increasingly depends on documented ingredients, testing, labeling, dosage, and supply chain controls
If Great Britain is part of your CBD growth strategy, complete our quick Puro Risk intake form so you can map product compliance, ingredient sourcing, testing, inventory, contracts, and insurance exposure before formal authorization changes competitive expectations.
Why these recommendations matter
CBD products have existed in Great Britain's retail market for years while regulators worked through the novel food authorization process.
The Food Standards Agency created an interim public list to identify products connected to applications that were progressing through regulatory review.
Being listed did not mean those products had received full authorization.
The new recommendations represent a major step toward changing that status for products connected to the three qualifying applications, provided they satisfy the final authorized specifications and conditions of use.
For operators, that begins to separate products supported by completed regulatory work from products with weaker or incomplete compliance pathways.
Why ingredient sourcing becomes more important
Novel food authorization is tied to specific ingredients and manufacturing processes.
A company cannot assume that any CBD isolate becomes acceptable simply because another supplier receives authorization.
Operators need to know which ingredient is used in each product, which novel food application supports it, whether the ingredient meets the approved specifications, and whether the finished product follows the permitted conditions of use.
That makes supplier documentation increasingly valuable.
Why labels may need another review
The proposed authorizations include conditions around daily intake and consumer warnings.
The Food Standards Agency currently uses a provisional acceptable daily intake of 10 milligrams of CBD for healthy adults.
Labels connected to authorized products would need to communicate applicable use conditions and warnings, including guidance for consumers taking medication and other identified groups.
Manufacturers should therefore review more than the amount of CBD inside a product.
Serving instructions, package size, warnings, intended consumer, product format, and total daily intake can all affect compliance.
Why controlled cannabinoids still matter
CBD purity does not eliminate controlled cannabinoid concerns.
The proposed specifications include limits involving delta 9 THC and other controlled cannabinoids.
That means manufacturers need laboratory data capable of demonstrating that ingredients and finished products remain within applicable specifications.
Consistent testing becomes particularly important when products are manufactured across multiple batches or supplied by several ingredient producers.
Why authorization could reshape competition
Formal authorization can raise the cost of participating in the market.
Companies with completed safety assessments, documented ingredient sourcing, reliable testing, and compliant labels may gain stronger market access while weaker products face greater scrutiny.
For retailers, authorization could also make purchasing decisions more structured.
If formal CBD authorization could change which products you manufacture or stock, complete the Puro Risk intake form to identify inventory, supplier, product, contract, and insurance risks before purchasing commitments are renewed.
Conclusion
Great Britain is moving closer to turning its established CBD market into a formally authorized food category.
The three recommendations do not mean every linked product has already received final approval. The Food Standards Agency board must consider the recommendations, and final government authorization is still required.
The direction is important nonetheless.
Operators that can document ingredient identity, manufacturing, testing, dosage, labeling, and supply chain compliance will be better positioned as the market moves away from temporary regulatory arrangements.
The universal lesson extends beyond Great Britain. As CBD markets mature, regulatory credibility becomes part of market access.
Educational note: This article is for education only and is not legal, regulatory, medical, food safety, product compliance, financial, investment, manufacturing, or insurance advice.
What to do this week
• Confirm which novel food application supports each CBD ingredient you use
• Review CBD purity and controlled cannabinoid testing records
• Compare serving instructions with the 10 milligram daily intake guidance
• Review labels for required consumer warnings and usage information
• Confirm suppliers can provide current manufacturing and ingredient documentation
• Identify inventory that could be exposed if its supporting application does not receive authorization
FAQ
Has Great Britain formally authorized these CBD products yet?
No. The Food Standards Agency has recommended authorization, but additional regulatory and government steps remain before final authorization.
How many products could be affected?
Approximately 3,000 products on the existing CBD Public List are linked to the three applications.
Which companies submitted the applications?
The applications involve Chanelle McCoy CBD Ltd., Cannaray Brands Ltd., and EIHA projects GmbH.
How much CBD does the Food Standards Agency recommend per day?
The agency currently uses a provisional acceptable daily intake of 10 milligrams of CBD per day for a healthy adult.
Does being on the CBD Public List mean a product is already authorized?
No. The list has functioned as an interim regulatory tool for products linked to progressing novel food applications.
What is the biggest operator takeaway?
Formal authorization makes ingredient sourcing, testing, labeling, dosage, supplier documentation, and regulatory traceability increasingly important to market access.
Great Britain CBD novel food authorization review
You might also like
SOURCES
The Marijuana Herald, Great Britain Moves Toward First Ever CBD Novel Food Authorizations, Covering About 3,000 Products, September 3, 2026
The report identifies the three applications, approximately 3,000 linked products, proposed conditions, September 16 board consideration, and remaining government authorization process.
Food Standards Agency, Consultation On Applications For Authorisation Of Three Cannabidiol Food Products As Novel Foods
The Food Standards Agency identifies the three novel food applications and explains the authorization process for CBD food products in Great Britain.
Food Standards Agency, Register Of CBD Products Linked To Novel Food Applications
https://data.food.gov.uk/cbd-products/products-list/guidance
The official register explains that products on the list are connected to progressing novel food applications but are not formally authorized simply because they appear on the list.
Great Britain is moving toward its first formal CBD novel food authorizations, with three applications linked to approximately 3,000 existing products. The shift could create clearer market access while increasing pressure around ingredient sourcing, testing, labeling, daily intake guidance, and controlled cannabinoid limits.